EVIDENCE PROFILE / PUBLISHED
Semax
Semax is described as a synthetic ACTH-fragment-derived heptapeptide; exact formulation and jurisdiction are essential to interpreting regional reports. Older Russian-language controlled reports describe stroke populations, but accessible methods, blinding, formulations, and independent replication are limited.
Evidence at a glance
- Human
- LimitedOlder controlled reports in stroke patients, with limited accessible methods.
- Animal/cell
- Not rated
- Approved medicine
- Not rated
Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.
PREPPY BOY ASKS
“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”
The catalogue name is a starting point, not proof of formulation or identity. Research explores neurotrophic signaling, ischemia models, and neurological recovery markers.
Identity
Semax is described as a synthetic ACTH-fragment-derived heptapeptide; exact formulation and jurisdiction are essential to interpreting regional reports.
Biological mechanism or research interest
Research explores neurotrophic signaling, ischemia models, and neurological recovery markers.
Verified approved human uses
No Canadian or U.S. approved use was verified in the reviewed sources. Regional use reports are not treated as worldwide approval.
Investigational human evidence
Older Russian-language controlled reports describe stroke populations, but accessible methods, blinding, formulations, and independent replication are limited.
Popular claims versus demonstrated findings
Cognition, focus, neuroprotection, and stroke-recovery claims are not established for an unspecified catalogue material.
Human versus animal or cell evidence
Much mechanistic literature is animal or cellular and cannot establish human clinical outcomes.
Limitations and known risks
FDA notes limited route-specific safety information and peptide impurity or immunogenicity concerns; long-term human safety is unclear.
